|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The significance of circulating vascular endothelial growth factor (VEGF) protein in gastric cancer显示文摘 | Manabu Ohta Hiroyuki Konno Tatsuo Tanaka Megumi Baba Kinji Kamiya Tuyoshi Syouji Kenji Kondoh Masaya Watanabe Hirofumi Terada Satoshi Nakamura | 2002 | Cancer Letters2002，，2： | 2 |
| 2 | Evaluation of Humoral Immunity to Mycobacterium tuberculosis -Specific Antigens for Correlation with Clinical Status and Effective Vaccine Development显示文摘 | Mamiko Niki Maho Suzukawa Shunsuke Akashi Hideaki Nagai Ken Ohta Manabu Inoue Makoto Niki Yukihiro Kaneko Kozo Morimoto Atsuyuki Kurashima Seigo Kitada Sohkichi Matsumoto Koichi Suzuki Yoshihiko Hoshino Pedro A. Reche | 2015 | Journal of Immunology Research2015，，： | 1 |
| 3 | Outcome of repeat hepatectomy in patients with hepatocellular carcinoma aged 75 years and older显示文摘 | Eiji Tsujita Tohru Utsunomiya Mitsuhiko Ohta Tetsuzo Tagawa Ayumu Matsuyama Jin Okazaki Manabu Yamamoto Shin-ichi Tsutsui Teruyoshi Ishida | 2010 | Surgery2010，，5： | 1 |
| 4 | Mesenteric paraganglioma: Report of a case显示文摘We report a rare case of paraganglioma that developed in the mesentery of terminal ileum. A 78-year-old woman complained of right-sided abdominal pain. Abdominal computed tomography revealed a solid heterogeneously enhanced mass in the right lower abdomen. The tumor was laparoscopically excised. The mesenteric tumor was well circumscribed, ovoid, and encapsulated and measured 3 cm × 1.5 cm × 1.5 cm. Histological examination showed a cellular neoplasm comprised of nests and groups of tumor cells separated by fibrovascular connective tissue, giving a characteristic nested Zellballen pattern. Immunohistochemically, the tumor cells were positive for chromogranin, synaptophysin, CD56, and vimentin and negative for cytokeratins, SMA, CD34, CD117/c-kit and S100. On the basis of histologic and immunohistochemical features, a diagnosis of mesenteric paraganglioma was made. The operative and postoperative courses were unremarkable, and the patient was discharged on postoperative day 7. She was doing well 1 year after the surgery with no signs of recurrence. Extra-adrenal paragangliomas most commonly develop adjacent to the aorta, particularly the area corresponding to the organ of Zuckerkandl. Mesenteric paraganglioma, as in our case, is extremely rare; only 11 cases have been reported in the literature. We herein discuss the clinical findings of these cases. | Takeshi Fujita Kinji Kamiya Yoshiaki Takahashi Shinichiro Miyazaki Ichirota Iino Hirotoshi Kikuchi Yoshihiro Hiramatsu Manabu Ohta Satoshi Baba Hiroyuki Konno | 2013 | World Journal of Gastrointestinal Surgery2013，5，3： | 1 |
| 5 | Application of IgY to sandwich enzyme-linked immunosorbent assays, lateral flow devices, and immunopillar chips for detecting staphylococcal enterotoxins in milk and dairy products显示文摘 | Wanchun Jin Keiko Yamada Mai Ikami Noritada Kaji Manabu Tokeshi Yusuke Atsumi Makoto Mizutani Atsushi Murai Akira Okamoto Takao Namikawa Yoshinobu Baba Michio Ohta | 2013 | Journal of Microbiological Methods2013，，3： | 1 |
| 6 | Poorly differentiated endocrine carcinoma of the pancreas responded to gemcitabine:Case report显示文摘Poorly differentiated endocrine carcinoma (PDEC) of the pancreas is a rare and aggressive tumor. First-line treatment is commonly a combination of etoposide and cisplatin, but there is no consensus regarding further treatment recommendations. In this report, we describe a case of pancreatic PDEC treated with gemcitabine as third-line chemotherapy. A 62-year-old man with pancreatic PDEC was administered etoposide plus cisplatin as first-line treatment; he then received irinotecan for tumor relapse. However, because irinotecan induced ileus in this patient, we chose gemcitabine as thirdline chemotherapy. After two cycles of gemcitabine (1000 mg/m2 on days 1, 8 and 15 every 4 wk), a partialtumor response was noted by computed tomography (approximately 68% reduction in tumor size). Our patient survived for 15 mo after diagnosis. This is a rare case of unresectable pancreatic PDEC, which showed a partial response to gemcitabine after the failure of two other regimens. Gemcitabine could be an effective treatment option for pancreatic PDEC that is resistant to other treatments. | Shoichi Nakazuru Toshiyuki Yoshio Shigeki Suemura Mari Itoh Manabu Araki Chiaki Yoshioka Makiyo Ohta Yuka Sueyoshi Takashi Ohta Hiroko Hasegawa Kaori Morita Takashi Toyama Noriyoshi Kuzushita Yoshinori Kodama Masayuki Mano Eiji Mita | 2010 | World Journal of Gastroenterology2010，16，30： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员